Enalaprilat

kininogen 1 ; Homo sapiens







39 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32766265 Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants. 2020 1
2 30333824 Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency. 2018 1
3 24516103 Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition. 2014 May 1
4 24639651 Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists. 2014 4
5 21864683 Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue. 2011 Nov 1
6 18180402 Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. 2008 Feb 1
7 18259028 17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women. 2008 Apr 1
8 17716647 Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. 2007 Dec 22 1
9 15475593 Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain. 2005 Feb 1
10 16166566 Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men. 2005 Nov 1
11 14694157 Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. 2004 Jan 4
12 12566370 Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. 2003 Feb 4 2
13 12623947 Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans. 2003 Mar 1
14 11880373 Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. 2002 May 10 2
15 11741551 Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. 2001 Dec 15 2
16 10714896 Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor- inhibition on transcapillary glucose transport in humans. 2000 2
17 10900238 Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin. 2000 Aug 1
18 9951431 Inhibition of angiotensin-converting enzyme in human hand veins. 1999 Jan 2
19 10027827 Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts. 1999 Mar 1
20 10080484 Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin. 1999 Mar 1
21 10082496 Enhancement of bradykinin and resensitization of its B2 receptor. 1999 Mar 3
22 10096262 Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. 1999 Mar 1
23 10404842 Effect of enalaprilat on nitric oxide activity in coronary artery disease. 1999 Jul 1 1
24 10458510 Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. 1999 2
25 10532602 Anomaly of the des-Arg9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusions: a preliminary study. 1999 Oct 1
26 10596866 Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. 1999 Sep 2
27 9207629 Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. 1997 Jul 1
28 9374762 Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study. 1997 Nov 2
29 8874148 Analysis of responses to angiotensin I and angiotensin I-(3-10) in the mesenteric vascular bed of the cat. 1996 Aug 15 1
30 8897926 Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat. 1996 Oct 4
31 7890486 Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists. 1995 Mar 2
32 8067439 Analysis of responses to bradykinin: effects of Hoe-140 in the hindquarters vascular bed of the cat. 1994 Aug 1
33 7508047 Different effects of angiotensin-converting enzyme inhibition in human arteries and veins. 1993 1
34 1281378 Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme. 1992 1
35 1663586 Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. 1991 Jul 1
36 1720843 Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators. 1991 Sep 1
37 1849639 Necrotizing tracheobronchitis (NTB) following high frequency ventilation: role of an angiotensin converting enzyme inhibitor. 1991 Jan-Feb 1
38 2557432 Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. 1989 May 1
39 2852237 Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels. 1988 Dec 1